Article

A comparative in vitro microbiological evaluation of generic meropenem compounds against the innovator compound

Published in: Southern African Journal of Epidemiology and Infection
Volume 26 , issue 2 , 2011 , pages: 73–77

DOI: 10.1080/10158782.2011.11441428

Author(s): W Lowman Infection Control Services Laboratory, National Health Laboratory Services, , R Stewart Infection Control Services Laboratory, National Health Laboratory Services, , N Aithma Infection Control Services Laboratory, National Health Laboratory Services, , Z Mjindi Infection Control Services Laboratory, National Health Laboratory Services, , J Loakes Infection Control Services Laboratory, National Health Laboratory Services,

Keywords: MIC , meropenem , generic , MBC

Download full text Get new issue alerts

Abstract

Background: Meropenem is a broad-spectrum carbapenem widely used in the treatment of critically ill patients. A generic meropenem product has recently become available in South Africa and we aimed to compare the generic product with the innovator product using established in vitro microbiological testing methods.

« Focus on hepatitis A and the traveller

Assessment of existing practices in the operating theatre in the Khartoum North Teaching Hospital, Sudan »